Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Clinical trial NCT06374459 · RECRUITING
Trial details
- NCT number
- NCT06374459
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2032-05-31
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.